full Prescribing Information and Medication Guide, including With ACTEMRA IV infusions, you may be able to treat your moderate to severe RA with or without. Full Prescribing Information ACTEMRA is indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis (RA) who have. Actemra® (tocilizumab) pre-filled syringe for subcutaneous (SC) injection. Patients Consumer Medicine Information (CMI). Healthcare Professionals.
|Published (Last):||21 January 2004|
|PDF File Size:||7.9 Mb|
|ePub File Size:||15.34 Mb|
|Price:||Free* [*Free Regsitration Required]|
Limited available data in pregnant women are not sufficient to determine whether there is a drug-associated risk for major birth defects and miscarriage. Genentech does not recommend and does niformation endorse the content on any third-party websites.
Rheumatoid Arthritis Treatment | ACTEMRA® (tocilizumab)
Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites. An infection, think you may infprmation an infection, are being treated for an infection, or get a lot of infections that return. The rate of serious infections was 9. One of these events, urticaria, was considered serious.
Tell your healthcare provider right away if prescribibg see any of these side effects: You may also have changes in other laboratory tests, such as your blood cholesterol levels.
Gastrointestinal Perforations Events of gastrointestinal GI perforation have been reported in clinical trials, primarily as complications of diverticulitis in RA patients.
SC Administration Indicated only in adults with rheumatoid arthritis Rotate SC injection sites ie, thighs, abdomen, outer area of upper arm [caregiver only] and inject full amount of the syringe 0. The fully diluted tocilizumab solutions for infusions should be stored at 36 — 46 degrees Fahrenheit or at room temperature for up to 24 hours. A total of Infusion Reactions In PJIA informtion, infusion-related reactions are defined as all events occurring during or within 24 hours of an infusion.
Share Email Print Feedback Close. Your doctor also has to fill out a form called the SMN. If you had hives, a rash, or experienced flushing after injecting, you should tell your healthcare provider or nurse before your next injection.
Patients with invasive fungal infections may present with disseminated, rather than localized, disease. If you have systemic juvenile idiopathic arthritis SJIA you will have blood tests done every 2 to 4 weeks during treatment. Patients less than 30 actejra weight: After dilution for IV administration: Pre-Infusion Checklist Confirm the following: Formulary Formulary Patient Discounts.
The information contained in this section of the site is intended for U.
Please select a treatment to continue
Your cholesterol levels should be checked 4 to 8 weeks after the start of your treatment, and then every 6 months after that. Active tuberculosis, which may present with pulmonary or extrapulmonary disease. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for prescrjbing sites.
Your healthcare provider may stop your ACTEMRA treatment for a period of time or change your dose of medicine if needed because of changes in these blood test results.
In SC-II, the frequency of injection-site reactions was 7.
The limited available data with ACTEMRA in pregnant women are not sufficient to determine whether there is a drug-associated risk for major birth defects and miscarriage. This can make you more likely to get infections or make any current infection worse. ACTEMRA is indicated for the treatment of active systemic juvenile idiopathic arthritis in patients 2 years of age and older.
To learn more, call or talk to your healthcare provider to register. During the 1-year study, a frequency of Genentech does not recommend and does not endorse the content on any third-party websites. Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.
If particulates and discoloration are noted, the product should not be used.
Animal studies show risk and human studies not available or neither animal informatiln human studies done. Click “OK” actemea you are a healthcare professional. The most commonly reported serious infections included pneumonia, gastroenteritis, varicella, and otitis media. Here you can download the form you need to enroll in Genentech Rheumatology Access Solutions and other important information.
IV dosing Tocilizumab is given as a 60 minute single intravenous drip infusion. Brand and Other Names: This restriction typically requires that certain criteria be met prior to approval for the prescription. Prior Authorization Drugs that require prior authorization.
Preescribing Restrictions Drugs that have restrictions other than prior authorization, quantity limits, and step therapy associated with each prescription. The infusion should be administered over 60 minutes, and must be administered with an infusion set.
You may also call Genentech at